Currently, several therapies are used for the COVID-19 treatment to reduce the overwhelmed inflammation and the SARS-CoV-2-mediated activation, such as IL-1β inhibitors, IL-6 inhibitors, JAK-inhibitors, and corticosteroids (19–21). Here, IL1B is linked to COVID-19.